Live-attenuated bacterial vaccines
This page catalogs 3 BCG (Bacillus Calmette-Guérin) vaccine products. BCG is the most widely administered vaccine in history, first used in humans in 1921. It provides variable protection against pulmonary tuberculosis but is effective against severe childhood TB forms including TB meningitis.
Last updated: April 2026.
| Trade Name | Generic Designation | Manufacturer | Vaccine Type | Regulatory Status & Year | Key Notes |
|---|---|---|---|---|---|
| BCG (generic) | Bacillus Calmette-Guérin live-attenuated M. bovis | Various (Merck, Sanofi, others) | Live-attenuated bacterial | FDA Licensed (Merck TICE strain) | First human use 1921; most widely administered vaccine in history |
| TICE-BCG | BCG vaccine (Tice strain) | Merck | Live-attenuated bacterial | FDA Licensed | US-licensed BCG |
| Mycobax | BCG vaccine | Sanofi Pasteur | Live-attenuated bacterial | Licensed (non-US) | Sanofi Pasteur product |
Regulatory data sourced from FDA CBER Vaccines Licensed for Use in the United States (March 2026) and WHO records. Catalog scope and historical context informed by Khan, Shaz, The Ultimate Vaccine Timeline.